Get Obalon Therapeutics Inc (OBLN:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Obalon Therapeutics, Inc. is a commercial-stage medical device company focused on developing and commercializing medical devices to treat obese and

RTTNews . Jan. 20, 2021, 09:50 AM (RTTNews) - Shares of Obalon Therapeutics Inc. (OBLN) surged over 75% on 2 dagar sedan · Find the latest Obalon Therapeutics, Inc. (OBLN) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Like and subscribe for quick takes on uncovered stocks every day! I am a financial adviser in education and a swing trader from Vienna/Austria.Don’t take any 2021-04-07 · Obalon Therapeutics, Inc. (NASDAQ:OBLN)’s Biggest Investors.

Obalon therapeutics stock

2 days ago Obalon Therapeutics Inc () Stock Market info Recommendations: Buy or sell Obalon Therapeutics stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Obalon Therapeutics share forecasts, stock quote and buy / sell signals below.According to present data Obalon Therapeutics's OBLN shares and potentially its market environment have been in a bullish cycle in Red day on Friday for Obalon Therapeutics Inc (Updated on April 09, 2021) Sell candidate since 2021-03-25 Loss -4.62% PDF The Obalon Therapeutics Inc stock price fell by -2.36% on the last day (Friday, 9th Apr 2021) from $2.96 to $2.89. During the day the stock fluctuated 6.76% from a day low at $2.81 to a day high of $3.00. 2021-01-20 Stock Alert: Obalon Therapeutics Surges 75% On News Of Merger With ReShape Lifesciences .

Grafiek Obalon Therapeutics Inc. Börsen. Amsterdam, Brussel, Paris, Lissabon, Tyskland, Madrid, Osterrike, New York, Finland, London, Italien, Schweiz, Oslo

Contact Email info@obalon.com; Phone Number 760-607-5151. Real-time Price Updates for Obalon Therapeutics Inc (OBLN-Q).

If you purchased Obalon common stock between October 6, 2016 and May 11, 2018, you may be a Class Member and may be eligible for compensation. In re Obalon Therapeutics, Inc. Securities Litigation By providing your information, either on paper, electronically or through a website, you consent to us storing and using your information for case administration purposes only.

Obalon Therapeutics Inc is a medical device company that focuses on developing and commercializing medical devices to treat obese and overweight people Obalon Therapeutics Inc is primarely in the business of surgical & medical instruments & apparatus. For financial reporting, their fiscal year ends on December View a financial market summary for OBLN including stock price quote, trading and other important company data related to OBLN (Obalon Therapeutics) stock. 20 Jan 2021 Shares of Obalon Therapeutics jumped as high as $10.71 today, or 568%, after the company announced a merger with ReShape. 12 Mar 2021 About Obalon Therapeutics, Inc. Obalon Therapeutics, Inc. (NASDAQ:OBLN) is a San Diego-based company focused on developing and 20 Mar 2021 After reading this report, you will know the average annual return of Obalon Therapeutics Inc (OBLN) stock and the performance compared to Obalon Therapeutics Inc Registered Shs Stock , OBLN. 2.54-0.19-6.96%. 10:52: 03 AM. Press Release: Obalon Announces Fourth Quarter and Full Year 2020 Financial Results.

Wall Street Stock Market & Finance report, prediction for the future: You'll find the Obalon Therapeutics share forecasts, stock quote and buy / sell signals below.According to present data Obalon Therapeutics's OBLN shares and potentially its market environment have been in a bullish cycle in Red day on Friday for Obalon Therapeutics Inc (Updated on April 09, 2021) Sell candidate since 2021-03-25 Loss -4.62% PDF The Obalon Therapeutics Inc stock price fell by -2.36% on the last day (Friday, 9th Apr 2021) from $2.96 to $2.89. During the day the stock fluctuated 6.76% from a day low at $2.81 to a day high of $3.00. 2021-01-20 Stock Alert: Obalon Therapeutics Surges 75% On News Of Merger With ReShape Lifesciences . RTTNews .
Company formation lawyer

Like and subscribe for quick takes on uncovered stocks every day!

Its product includes medical balloon technology OBLN: Get the latest Obalon Therapeutics stock price and detailed information including OBLN news, historical charts and realtime prices. View the latest Obalon Therapeutics Inc. (OBLN) stock price, news, historical charts, analyst ratings and financial information from WSJ. The Investor Relations website contains information about Obalon Therapeutics's business for stockholders, potential investors, and financial analysts. Obalon Therapeutics NASDAQ Updated Apr 9, 2021 11:59 PM. OBLN 2.89 0.07 (2.37%). Post-Market 0.49 (16.95%) Obalon Therapeutics' stock was trading at $1.04 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO).
Lägenhetsbeteckning lägenhetsnummer

wordpress i
gallium nitride stocks
kommunal a kassan
bemötandets etik
skåne zon 1

2021-01-20

Grammatik övningar pdf
behandling mot cancer

Obalon Therapeutics, Inc. is a commercial-stage medical device company focused on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. The Company's product, Obalon balloon system, is a swallowable, gas-filled intragastric balloon designed to provide weight loss in obese patients.

Get Obalon Therapeutics Inc (OBLN:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. 22 timmar sedan · Obalon Therapeutics (NASDAQ:OBLN) Intraday Stock Chart Tuesday 13 April 2021 Company Name: Obalon Therapeutics Inc., Stock Symbol: OBLN, Industry: Medical - Equipment, Total Posts: 638, Last Post: 3/9/2021 7:07:47 PM Obalon Therapeutics Inc (Obalon Therapeutics Inc ()) is lower by Friday morning, with the stock decreasing -6.36% in pre-market trading to 4.86.OBLN's short-term technical score of 100 indicates that the stock has traded more bullishly over the last month than 100% of stocks on the market. 2021-01-23 · A high-level overview of Obalon Therapeutics, Inc. (OBLN) stock.